nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—ABCB1—colon cancer	0.759	1	CbGaD
Fluticasone furoate—ABCB1—Irinotecan—colon cancer	0.0447	0.284	CbGbCtD
Fluticasone furoate—ABCB1—Vincristine—colon cancer	0.0391	0.248	CbGbCtD
Fluticasone furoate—CYP3A4—Irinotecan—colon cancer	0.0268	0.17	CbGbCtD
Fluticasone furoate—ABCB1—Methotrexate—colon cancer	0.0237	0.15	CbGbCtD
Fluticasone furoate—CYP3A4—Vincristine—colon cancer	0.0234	0.149	CbGbCtD
Fluticasone furoate—Nasal irritation—Fluorouracil—colon cancer	0.00829	0.0998	CcSEcCtD
Fluticasone furoate—Prolonged menses—Vincristine—colon cancer	0.00735	0.0886	CcSEcCtD
Fluticasone furoate—Nasal discomfort—Fluorouracil—colon cancer	0.00503	0.0606	CcSEcCtD
Fluticasone furoate—Menorrhagia—Vincristine—colon cancer	0.00208	0.0251	CcSEcCtD
Fluticasone furoate—Impaired healing—Methotrexate—colon cancer	0.00173	0.0208	CcSEcCtD
Fluticasone furoate—Ulcer—Irinotecan—colon cancer	0.00159	0.0191	CcSEcCtD
Fluticasone furoate—Herpes simplex—Fluorouracil—colon cancer	0.00156	0.0188	CcSEcCtD
Fluticasone furoate—Ulcer—Fluorouracil—colon cancer	0.00152	0.0183	CcSEcCtD
Fluticasone furoate—Pharyngolaryngeal pain—Capecitabine—colon cancer	0.00149	0.0179	CcSEcCtD
Fluticasone furoate—Laryngeal pain—Capecitabine—colon cancer	0.00147	0.0178	CcSEcCtD
Fluticasone furoate—Dysphonia—Capecitabine—colon cancer	0.00122	0.0147	CcSEcCtD
Fluticasone furoate—Visual disturbance—Irinotecan—colon cancer	0.00115	0.0138	CcSEcCtD
Fluticasone furoate—Herpes simplex—Capecitabine—colon cancer	0.00109	0.0131	CcSEcCtD
Fluticasone furoate—Ulcer—Capecitabine—colon cancer	0.00106	0.0128	CcSEcCtD
Fluticasone furoate—Cataract—Capecitabine—colon cancer	0.00106	0.0127	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Capecitabine—colon cancer	0.001	0.0121	CcSEcCtD
Fluticasone furoate—Candida infection—Capecitabine—colon cancer	0.000959	0.0116	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Fluorouracil—colon cancer	0.000933	0.0112	CcSEcCtD
Fluticasone furoate—Herpes simplex—Methotrexate—colon cancer	0.000811	0.00977	CcSEcCtD
Fluticasone furoate—Ulcer—Methotrexate—colon cancer	0.00079	0.00952	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Fluorouracil—colon cancer	0.000782	0.00941	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Vincristine—colon cancer	0.00076	0.00916	CcSEcCtD
Fluticasone furoate—Epistaxis—Fluorouracil—colon cancer	0.000758	0.00914	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Irinotecan—colon cancer	0.000741	0.00892	CcSEcCtD
Fluticasone furoate—Visual impairment—Irinotecan—colon cancer	0.000726	0.00875	CcSEcCtD
Fluticasone furoate—Migraine—Capecitabine—colon cancer	0.000718	0.00864	CcSEcCtD
Fluticasone furoate—Pharyngitis—Fluorouracil—colon cancer	0.000716	0.00863	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Vincristine—colon cancer	0.000697	0.0084	CcSEcCtD
Fluticasone furoate—Immune system disorder—Irinotecan—colon cancer	0.000681	0.0082	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Irinotecan—colon cancer	0.000679	0.00818	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Capecitabine—colon cancer	0.000652	0.00785	CcSEcCtD
Fluticasone furoate—Back pain—Vincristine—colon cancer	0.000652	0.00785	CcSEcCtD
Fluticasone furoate—Back pain—Irinotecan—colon cancer	0.000635	0.00764	CcSEcCtD
Fluticasone furoate—Agitation—Vincristine—colon cancer	0.000619	0.00746	CcSEcCtD
Fluticasone furoate—Bronchitis—Capecitabine—colon cancer	0.000606	0.0073	CcSEcCtD
Fluticasone furoate—Visual disturbance—Methotrexate—colon cancer	0.000573	0.0069	CcSEcCtD
Fluticasone furoate—Cough—Irinotecan—colon cancer	0.000572	0.0069	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Vincristine—colon cancer	0.00055	0.00662	CcSEcCtD
Fluticasone furoate—Infection—Vincristine—colon cancer	0.000546	0.00658	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Capecitabine—colon cancer	0.000546	0.00658	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Vincristine—colon cancer	0.000539	0.00649	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Irinotecan—colon cancer	0.000535	0.00645	CcSEcCtD
Fluticasone furoate—Infection—Irinotecan—colon cancer	0.000532	0.00641	CcSEcCtD
Fluticasone furoate—Epistaxis—Capecitabine—colon cancer	0.00053	0.00638	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Irinotecan—colon cancer	0.000525	0.00633	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Fluorouracil—colon cancer	0.000513	0.00618	CcSEcCtD
Fluticasone furoate—Infection—Fluorouracil—colon cancer	0.000509	0.00614	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Fluorouracil—colon cancer	0.000503	0.00606	CcSEcCtD
Fluticasone furoate—Pharyngitis—Capecitabine—colon cancer	0.000501	0.00603	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Capecitabine—colon cancer	0.000496	0.00597	CcSEcCtD
Fluticasone furoate—Visual impairment—Capecitabine—colon cancer	0.000486	0.00586	CcSEcCtD
Fluticasone furoate—Dyspnoea—Irinotecan—colon cancer	0.000477	0.00575	CcSEcCtD
Fluticasone furoate—Eye disorder—Capecitabine—colon cancer	0.000471	0.00568	CcSEcCtD
Fluticasone furoate—Dyspnoea—Fluorouracil—colon cancer	0.000457	0.00551	CcSEcCtD
Fluticasone furoate—Immune system disorder—Capecitabine—colon cancer	0.000456	0.00549	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Capecitabine—colon cancer	0.000455	0.00548	CcSEcCtD
Fluticasone furoate—Body temperature increased—Vincristine—colon cancer	0.000435	0.00524	CcSEcCtD
Fluticasone furoate—Back pain—Capecitabine—colon cancer	0.000425	0.00512	CcSEcCtD
Fluticasone furoate—Body temperature increased—Irinotecan—colon cancer	0.000423	0.0051	CcSEcCtD
Fluticasone furoate—Tremor—Capecitabine—colon cancer	0.000411	0.00496	CcSEcCtD
Fluticasone furoate—Urticaria—Fluorouracil—colon cancer	0.000407	0.00491	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Methotrexate—colon cancer	0.000407	0.0049	CcSEcCtD
Fluticasone furoate—Body temperature increased—Fluorouracil—colon cancer	0.000405	0.00488	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Vincristine—colon cancer	0.000405	0.00488	CcSEcCtD
Fluticasone furoate—Epistaxis—Methotrexate—colon cancer	0.000394	0.00475	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Irinotecan—colon cancer	0.000394	0.00475	CcSEcCtD
Fluticasone furoate—Palpitations—Capecitabine—colon cancer	0.000388	0.00467	CcSEcCtD
Fluticasone furoate—Cough—Capecitabine—colon cancer	0.000383	0.00462	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Fluorouracil—colon cancer	0.000378	0.00455	CcSEcCtD
Fluticasone furoate—Diarrhoea—Vincristine—colon cancer	0.000376	0.00453	CcSEcCtD
Fluticasone furoate—Pharyngitis—Methotrexate—colon cancer	0.000373	0.00449	CcSEcCtD
Fluticasone furoate—Diarrhoea—Irinotecan—colon cancer	0.000366	0.00441	CcSEcCtD
Fluticasone furoate—Dizziness—Vincristine—colon cancer	0.000364	0.00438	CcSEcCtD
Fluticasone furoate—Visual impairment—Methotrexate—colon cancer	0.000362	0.00436	CcSEcCtD
Fluticasone furoate—Infection—Capecitabine—colon cancer	0.000356	0.00429	CcSEcCtD
Fluticasone furoate—Dizziness—Irinotecan—colon cancer	0.000354	0.00427	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Capecitabine—colon cancer	0.000351	0.00423	CcSEcCtD
Fluticasone furoate—Eye disorder—Methotrexate—colon cancer	0.000351	0.00423	CcSEcCtD
Fluticasone furoate—Diarrhoea—Fluorouracil—colon cancer	0.000351	0.00423	CcSEcCtD
Fluticasone furoate—Rash—Vincristine—colon cancer	0.000347	0.00418	CcSEcCtD
Fluticasone furoate—Dermatitis—Vincristine—colon cancer	0.000346	0.00417	CcSEcCtD
Fluticasone furoate—Headache—Vincristine—colon cancer	0.000344	0.00415	CcSEcCtD
Fluticasone furoate—Immune system disorder—Methotrexate—colon cancer	0.000339	0.00409	CcSEcCtD
Fluticasone furoate—Dizziness—Fluorouracil—colon cancer	0.000339	0.00408	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Methotrexate—colon cancer	0.000338	0.00408	CcSEcCtD
Fluticasone furoate—Rash—Irinotecan—colon cancer	0.000338	0.00407	CcSEcCtD
Fluticasone furoate—Dermatitis—Irinotecan—colon cancer	0.000337	0.00406	CcSEcCtD
Fluticasone furoate—Headache—Irinotecan—colon cancer	0.000335	0.00404	CcSEcCtD
Fluticasone furoate—Nausea—Vincristine—colon cancer	0.000327	0.00393	CcSEcCtD
Fluticasone furoate—Rash—Fluorouracil—colon cancer	0.000323	0.00389	CcSEcCtD
Fluticasone furoate—Dermatitis—Fluorouracil—colon cancer	0.000323	0.00389	CcSEcCtD
Fluticasone furoate—Headache—Fluorouracil—colon cancer	0.000321	0.00387	CcSEcCtD
Fluticasone furoate—Dyspnoea—Capecitabine—colon cancer	0.000319	0.00385	CcSEcCtD
Fluticasone furoate—Nausea—Irinotecan—colon cancer	0.000318	0.00383	CcSEcCtD
Fluticasone furoate—Back pain—Methotrexate—colon cancer	0.000316	0.00381	CcSEcCtD
Fluticasone furoate—Nausea—Fluorouracil—colon cancer	0.000305	0.00367	CcSEcCtD
Fluticasone furoate—Cough—Methotrexate—colon cancer	0.000285	0.00344	CcSEcCtD
Fluticasone furoate—Urticaria—Capecitabine—colon cancer	0.000285	0.00343	CcSEcCtD
Fluticasone furoate—Body temperature increased—Capecitabine—colon cancer	0.000283	0.00341	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Methotrexate—colon cancer	0.000267	0.00321	CcSEcCtD
Fluticasone furoate—Infection—Methotrexate—colon cancer	0.000265	0.00319	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Capecitabine—colon cancer	0.000264	0.00318	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Methotrexate—colon cancer	0.000262	0.00315	CcSEcCtD
Fluticasone furoate—Diarrhoea—Capecitabine—colon cancer	0.000245	0.00295	CcSEcCtD
Fluticasone furoate—Dyspnoea—Methotrexate—colon cancer	0.000238	0.00286	CcSEcCtD
Fluticasone furoate—Dizziness—Capecitabine—colon cancer	0.000237	0.00285	CcSEcCtD
Fluticasone furoate—Rash—Capecitabine—colon cancer	0.000226	0.00272	CcSEcCtD
Fluticasone furoate—Dermatitis—Capecitabine—colon cancer	0.000226	0.00272	CcSEcCtD
Fluticasone furoate—Headache—Capecitabine—colon cancer	0.000224	0.0027	CcSEcCtD
Fluticasone furoate—Nausea—Capecitabine—colon cancer	0.000213	0.00256	CcSEcCtD
Fluticasone furoate—Urticaria—Methotrexate—colon cancer	0.000212	0.00255	CcSEcCtD
Fluticasone furoate—Body temperature increased—Methotrexate—colon cancer	0.000211	0.00254	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Methotrexate—colon cancer	0.000197	0.00237	CcSEcCtD
Fluticasone furoate—Triamcinolone—PTGS2—colon cancer	0.000196	0.294	CrCbGaD
Fluticasone furoate—Diarrhoea—Methotrexate—colon cancer	0.000183	0.0022	CcSEcCtD
Fluticasone furoate—Dizziness—Methotrexate—colon cancer	0.000176	0.00212	CcSEcCtD
Fluticasone furoate—Rash—Methotrexate—colon cancer	0.000168	0.00203	CcSEcCtD
Fluticasone furoate—Dermatitis—Methotrexate—colon cancer	0.000168	0.00202	CcSEcCtD
Fluticasone furoate—Headache—Methotrexate—colon cancer	0.000167	0.00201	CcSEcCtD
Fluticasone furoate—Betamethasone—PTGS2—colon cancer	0.000161	0.241	CrCbGaD
Fluticasone furoate—Nausea—Methotrexate—colon cancer	0.000158	0.00191	CcSEcCtD
Fluticasone furoate—Betamethasone—ABCB1—colon cancer	0.000137	0.205	CrCbGaD
Fluticasone furoate—Dexamethasone—PTGS2—colon cancer	9.36e-05	0.14	CrCbGaD
Fluticasone furoate—Dexamethasone—ABCB1—colon cancer	7.96e-05	0.119	CrCbGaD
